MADISON, Wisconsin: Gene-chip maker NimbleGen Systems Inc. said Tuesday it will be bought out by pharmaceutical giant Roche in a deal worth $272.5 million (â?¬203.3 million).
Madison, Wis.-based NimbleGen announced in March it would file for public offering and had hoped to raise $75 million (â?¬56 million). But the company remained private and will be sold in its entirety to Roche, it announced in a news release.